Local anesthetics Flashcards

1
Q

3 parts of LA

A
  1. lipophilic group: usually benzene ring
  2. hydrophilic group: tertiary amine
  3. intermediate bond: hydrocarbon chain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

intermediate bond

A
  1. Ester: -CO-

2. Amide: -HNC-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ester LA

No ‘i’ prior to -caine

A
  1. Procaine
  2. Cocaine
  3. Chloroprocaine
  4. tetracaine
    pseudocholinesterase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amide

(contain an ‘i’ before -caine

A
  1. lidocaine
  2. bupivacaine
  3. ropivacaine
  4. mepivacaine
  5. prilocaine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Uptake: from fastest to slowest

Faster uptake–>higher plasma concentrations–>increasing chance of local anesthetic toxicity

A

Intravenous > tracheal > intercostal > caudal > paracervical > epidural > brachial plexus > sciatic > subcutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

factors influencing absorption and onset of action

A
  1. lipid solubility–>penetrate nerve membrane–>potency

2. pKa: lower–>more un-ionized–>speed of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

biotransformation & excretion

A

Ester: pseudocholinesterase —>water-soluble–>urine
Amide: liver P-450–>kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

enhance LA effects

A
  1. epinephrine: 5mcg/ml (1:200,000) to 20mcg/ml (1:50,000)–>vasoconstricting
  2. opioids
  3. alpha-adrenergic agonists: clonidine
  4. steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

informed consent: brachial plexus

A

bleeding, infection, nerve damage, persistent paresthesia or weakness, shortness of breath, and local anesthetic toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

paresthesia

A

a sensation of pricking, tingling, or creeping on the skin that has no objective cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Intralipid (20% lipid emulsion)

A

bolus of 1.5 mL/kg over 1 min–> 0.25 mL/kg/min x 30-60 min–>repeated boluses as needed for persistent asystole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

post pain control vs surgical anesthesia

A
  1. Bupivacaine & ropivacaine: long duration–>postop pain

2. Lidocaine & mepivacaine: surgical anesthesia (not post op pain d/t short duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dyspnea

A
  1. phrenic nerve: close to brachial plexus–>anesthetized–>unilateral diaphragm paralysis
  2. pneumothorax: MC in supraclavicular
  3. LA toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Increase risk of cardiovascular toxicity of bupivacaine

A
  1. pregnancy: progesterone
  2. hypoxemia
  3. respiratory acidosis (not alkalosis)
  4. hyperkalemia (rather than hypo)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What percentage of amide LA are excreted unchanged in urine

A

<5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Local anesthetic systemic toxicity (LAST)<—unintended intravascular injection or absorption

A
  1. intercostal > caudal epidural > lumbar epidural > brachial plexus > subcutaneous
  2. Risk factors: age, cardiac disease, hepatic dysfunction, hypoxemia, and acidosis
  3. CNS is more sensitive than cardiovascular system, except bupivacaine & etidocaine
17
Q

LA CNS toxicity

A
  1. benign: perioral numbness, tinnitus
  2. On cnetral inhibitory pathways: shivering, muscle tremors, tonic-clonic seizure
  3. depressant: coma, hypoventilation, respiratory arrest
18
Q

Cauda equina syndrome (CES)

A
  1. bowel & bladder dysfunction
  2. perineal sensory loss
  3. LE motor weakness
    Note: d/t diffuse injury to CE
    Risk factors: high dose & consentration, restricted distribution, vasoconstrictors, LA (lidociane highest)
19
Q

Transient neurologic symptoms (TNS)

A

Pain
1. uni- or bi-lateral
2. buttocks, LB, LEs
3. onset: usually 12-24 hrs after SA or EA
4. duration: 6hrs to 4 days
5. risk factors: lidocaine, lithotomy, obesity, knee arthroscopy, outpt surgery
Note: - neurologic PE

20
Q

Cardiac Toxicity

A
  1. CNS excitatory–>increase: HR, BP
  2. Direct cardiac–>arrhythmia, prolongation of PR & QRS, depression of SA & AV nodes, QT prolongation, VT, torsade de pintes, VF
21
Q

Regional anesthesia

A
  1. performed after Std ASA monitoring

2. Available: 20% intralipid emulsion, AMBU bag, O2

22
Q

ASRA

A

www.asra.com

23
Q

Allergy to LA

A
  1. Amide: extremely rare
  2. Ester: cross-reactivity to p-aminobenzoic acid (PABA)–>allergy (Ester LA metabolized to PABA)
  3. Preservatives: parabens
24
Q

preservatives/additives

A
  1. Methylparaben: in some multi-dose formulation of LA–>paraben–>allergy
  2. Metabisulfate: –>urticarial, flusing, pruritus, airway obstruction
  3. EDTA: i.t. –>nerve injury; Epid–>back muscle spasm
  4. Epi: 1) prolongation; 2) test dose
  5. Na2CO3: faster onset
25
Q

Epinephrine test dose

A
  1. epinephrine: 1:200,000
  2. Intravascuar injuection
    1) increased T vave
    2) increased/decreased HR
    3) increased BP
26
Q

Methemoglobinemia

A
  1. Prilocaine–>O=toluidine in liver–>oxidize HgB
  2. usu. seen >600mg
  3. cyanosis refractory to O2
  4. metHgb >15%—>anxiety, dyspnea, HA, weakness, n/V–>50%–>confusion, seizures, arrhythmias, hemodynamic instability, death
  5. metHgb: co-oximetry
  6. treated: methylene blue
27
Q

ECG w/ LAST

A

Initial ECG changes indicating cardiac toxicity from local anesthetics include peaked T waves, elevated ST segments, and a prolongation of PR and QRS intervals. Next, depression of the SA and AV nodes is observed. Finally, the QT interval is prolonged, leading to ventricular tachycardia, torsade de pointes and ventricular fibrillation.

28
Q

_____________ of amide local anesthetics is the most important factor determining clearance from plasma.

A

Protein Binding